M. Koukourakis

发表

Angiogenesis Relates to Estrogen Receptor Negativity, c-erbB-2 Overexpression and Early Relapse in Node-Negative Ductal Carcinoma of the Breast

A. Giatromanolaki, M. Koukourakis, C. Manolas, 2003, International journal of surgical pathology.

Hypoxia and activated VEGF/receptor pathway in multiple myeloma.

K. Gatter, A. Giatromanolaki, D. Margaritis, 2010, Anticancer research.

Pyruvate dehydrogenase and pyruvate dehydrogenase kinase expression in non small cell lung cancer and tumor-associated stroma.

A. Harris, K. Gatter, A. Giatromanolaki, 2005, Neoplasia.

Hypoxia inducible factor 1α and 2α overexpression in inflammatory bowel disease

E. Maltezos, A. Harris, K. Gatter, 2003 .

Mean platelet volume: a useful marker of inflammatory bowel disease activity

M. Koukourakis, E. Kouroumalis, A. Kapsoritakis, 2001, American Journal of Gastroenterology.

MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.

E. Kontomanolis, M. Koukourakis, 2015, MicroRNA.

MicroRNA: The Potential Regulator of Endometrial Carcinogenesis.

E. Kontomanolis, M. Koukourakis, 2015, MicroRNA.

Guidelines for the use and interpretation of assays formonitoring autophagy (3rd edition)

Sangeeta Khare, Xin Qi, Ying Wang, 2016 .

Lung autophagic response following exposure of mice to whole body irradiation, with and without amifostine.

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2011, Biochemical and Biophysical Research Communications - BBRC.

Hypoxia-activated tumor pathways of angiogenesis and pH regulation independent of anemia in head-and-neck cancer.

A. Harris, J. Pastorek, K. Gatter, 2004, International journal of radiation oncology, biology, physics.

Tumour angiogenesis: vascular growth and survival

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Angiogenesis vs. response after combined chemoradiotherapy of squamous cell head and neck cancer

A. Harris, V. Georgoulias, K. Gatter, 1999, International journal of cancer.

Radiation-induced autophagy in normal and cancer cells: Towards novel cytoprotection and radio-sensitization policies?

M. Koukourakis, C. Zois, 2009, Autophagy.

Association of hypoxia-inducible factors 1alpha and 2alpha with activated angiogenic pathways and prognosis in patients with endometrial carcinoma.

A. Harris, K. Gatter, A. Giatromanolaki, 2002, Cancer.

Hypoxia inducible factors 1α and 2α are associated with VEGF expression and angiogenesis in gallbladder carcinomas

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2006 .

c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.

A. Giatromanolaki, H. Turley, G. Bonsignore, 2000, Journal of immunotherapy.

Gamma histone 2AX (γ-H2AX)as a predictive tool in radiation oncology

M. Koukourakis, S. Pouliliou, 2014, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

Vascular density analysis in colorectal cancer patients treated with vatalanib (PTK787/ZK222584) in the randomised CONFIRM trials

A. Harris, G. Folprecht, A. Giatromanolaki, 2012, British Journal of Cancer.

Hypofractionated and accelerated radiotherapy with subcutaneous amifostine cytoprotection as short adjuvant regimen after breast-conserving surgery: interim report.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2009, International journal of radiation oncology, biology, physics.

Autophagy and hypoxia in colonic adenomas related to aggressive features

A. Harris, A. Giatromanolaki, M. Koukourakis, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC): a short, safe, and effective postoperative regimen for high-risk breast cancer patients.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2002, International journal of radiation oncology, biology, physics.

Combining the past and present to advance immuno-radiotherapy of cancer

M. Koukourakis, Ioannis M. Koukourakis, Ioannis M Koukourakis, 2021, International reviews of immunology.

VEGF gene sequence variation defines VEGF gene expression status and angiogenic activity in non-small cell lung cancer.

E. Maltezos, A. Giatromanolaki, D. Papazoglou, 2004, Lung cancer.

High intratumoral accumulation of stealth liposomal doxorubicin in sarcomas--rationale for combination with radiotherapy.

A. Giatromanolaki, M. Koukourakis, S. Koukouraki, 2000, Acta oncologica.

Radiation exposure to the hands of operators during angiographic procedures.

J. Damilakis, N. Gourtsoyiannis, M. Koukourakis, 1995, European journal of radiology.

Transcription Factor EB Expression in Early Breast Cancer Relates to Lysosomal/Autophagosomal Markers and Prognosis

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2017, Clinical breast cancer.

Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas

A. Harris, K. Gatter, A. Giatromanolaki, 2010, Journal of Clinical Pathology.

Light-chain 3A autophagic activity and prognostic significance in non-small cell lung carcinomas.

A. Giatromanolaki, Demosthenes Bouros, M. Koukourakis, 2011, Chest.

Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.

Athens Greece, K. Gatter, A. Giatromanolaki, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Immunohistochemical detection of senescence markers in human sarcomas.

A. Giatromanolaki, M. Koukourakis, M. Kouroupi, 2019, Pathology, research and practice.

Activated Vegfr2/kdr Pathway In Tumour Cells And Tumour Associated Vessels Of Colorectal Cancer

A. Giatromanolaki, H. Turley, M. Koukourakis, 2007, European journal of clinical investigation.

The angiogenic pathway ‘vascular endothelial growth factor/flk‐1(KDR)‐receptor’ in rheumatoid arthritis and osteoarthritis

A. Harris, K. Gatter, A. Giatromanolaki, 2001, The Journal of pathology.

Concurrent administration of Docetaxel and Stealth® liposomal doxorubicin with radiotherapy in non-small cell lung cancer : excellent tolerance using subcutaneous amifostine for cytoprotection

K. Romanidis, M. Koukourakis, G. Kyrgias, 2002, British Journal of Cancer.

Assessment of highly angiogenic and disseminated in the peripheral blood disease in breast cancer patients predicts for resistance to adjuvant chemotherapy and early relapse

D. Mavroudis, V. Georgoulias, M. Perraki, 2004, International journal of cancer.

Serum C-reactive Protein (CRP) Levels in Cancer Patients are Linked with Tumor Burden and are Reduced by Anti-hypertensive Medication

M. Koukourakis, G. Kambouromiti, D. Pitsiava, 2009, Inflammation.

Erythropoietin receptors in endometrial carcinoma as related to HIF1{alpha} and VEGF expression.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2009, In vivo.

Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy

A. Harris, D. Generali, A. Giatromanolaki, 2014, British Journal of Cancer.

Predictive Biomarkers and Personalized Medicine Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK 787 / ZK 222584 ( Vatalanib ) Antiangiogenic Therapy

A. Harris, G. Folprecht, K. Gatter, 2011 .

Angiogenic regeneration defines loco-regional recurrence following pre-operative radio-chemotherapy for rectal cancer: a pilot study

A. Giatromanolaki, M. Koukourakis, Stella Arelaki, 2019, Molecular Biology Reports.

Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study.

C. Simopoulos, A. Giatromanolaki, K. Romanidis, 2008, Anticancer research.

Diminutive polyps of large bowel should be an early target for endoscopic treatment.

M. Tzardi, G. Alexandrakis, M. Koukourakis, 2002, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A plesiotherapy technique for the post‐operative treatment of skin cancer using Ir192 microSelectron.

M. Koukourakis, P. Tsoutsou, I. Abatzoglou, 2008, Journal of applied clinical medical physics.

Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease.

M. Koukourakis, J. Manavis, Leonidas Sivridis, 2005, Clinical imaging.

Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α

A. Harris, A. Giatromanolaki, M. Koukourakis, 2007, Cancer Chemotherapy and Pharmacology.

Amifostine induces anaerobic metabolism and hypoxia-inducible factor 1α

A. Harris, A. Giatromanolaki, M. Koukourakis, 2003, Cancer Chemotherapy and Pharmacology.

Prognostic Relevance of the Relative Presence of CD4, CD8 and CD20 Expressing Tumor Infiltrating Lymphocytes in Operable Non-small Cell Lung Cancer Patients

A. Giatromanolaki, Aglaia Pappa, I. Anestopoulos, 2021, Anticancer Research.

Hypoxia and anaerobic metabolism relate with immunologically cold breast cancer and poor prognosis

A. Giatromanolaki, M. Koukourakis, S. Pouliliou, 2022, Breast Cancer Research and Treatment.

Towards a biological staging model for operable non-small cell lung cancer.

A. Harris, K. O'Byrne, A. Giatromanolaki, 2001, Lung cancer.

Prognostic Factors in Patients Presenting with Pleural Effusion Revealing Malignancy

A. Giatromanolaki, M. Koukourakis, K. Archontogeorgis, 2014, Respiration.

Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancer

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2000, Medical oncology.

Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.

A. Giatromanolaki, M. Koukourakis, V. Georgoulias, 1999, International journal of radiation oncology, biology, physics.

Hypofractionated radiotherapy with concurrent 5-fluorouracil radiosensitisation for recurrent or locally advanced colorectal cancer A phase II study

M. Koukourakis, A. Kapsoritakis, J. Skarlatos, 1996, International Journal of Colorectal Disease.

EXPRESSION OF THE INTESTINAL-TYPE ALKALINE PHOSPHATASE (IAPH) IN NORMAL AND MALIGNANT HUMAN TISSUES

A. Giatromanolaki, M. Koukourakis, Stella Arelaki, 2018 .

Down-regulation of intestinal-type alkaline phosphatase in the tumor vasculature and stroma provides a strong basis for explaining amifostine selectivity.

E. Maltezos, A. Giatromanolaki, M. Koukourakis, 2002, Seminars in oncology.

Outcome in Non-Small Cell Lung Cancer Relates to Angiogenic Pathways and Independently to Poor Expression of Hypoxia-inducible Carbonic Anhydrase-9 Updated Version

A. Harris, C. Wykoff, J. Pastorek, 2001 .

Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer.

I. Tentes, A. Giatromanolaki, E. Kontomanolis, 2011, Cytokine.

Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2005, Journal of Clinical Pathology.

Loss of expression and nuclear/cytoplasmic localization of the FOXP1 forkhead transcription factor are common events in early endometrial cancer: relationship with estrogen receptors and HIF-1α expression

A. Harris, A. Banham, K. Gatter, 2006, Modern Pathology.

Patterns of episialin/MUC1 expression in endometrial carcinomas and prognostic relevance

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2002, Histopathology.

Thymidine phosphorylase expression in normal and hyperplastic endometrium

A. Harris, K. Gatter, A. Giatromanolaki, 2000, Journal of clinical pathology.

Lectin-binding patterns in normal, hyperplastic and neoplastic endometrium: the prognostic value of concanavalin A

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2000, Virchows Archiv.

Metastatic cancer cells from c-erbB-2 negative primary breast cancer maintain the original c-erbB-2/HIF1α phenotype

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2007, Cancer biology & therapy.

A. Harris, K. Gatter, C. Simopoulos, 2004, Clinical Cancer Research.

Tumour angiogenic activity and vascular survival ability in bladder carcinoma

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2004, Journal of Clinical Pathology.

Hypoxia-inducible factors 1alpha and 2alpha are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin.

A. Harris, K. Gatter, A. Giatromanolaki, 2003, Melanoma research.

A. Harris, K. Gatter, A. Giatromanolaki, 2004, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival

A. Harris, K. Gatter, A. Giatromanolaki, 2011, Clinical & Experimental Metastasis.

One-lung ventilation and HIF1alpha expression in lung cancer and pneumothorax.

A. Giatromanolaki, G. Bougioukas, M. Koukourakis, 2010, Anticancer research.

Angiogenic Factor Expression in Hepatic Cirrhosis

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2007, Mediators of inflammation.

C2028T polymorphism in exon 12 and dinucleotide repeat polymorphism in intron 13 of the HIF-1alpha gene define HIF-1alpha protein expression in non-small cell lung cancer.

E. Maltezos, A. Harris, K. Gatter, 2006, Lung Cancer.

Differential effect of hypoxia and acidity on lung cancer cell and fibroblast metabolism.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2017, Biochemistry and cell biology = Biochimie et biologie cellulaire.

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC)

A. Harris, K. Gatter, A. Giatromanolaki, 2013, Angiogenesis.

The effect of trastuzumab/docatexel combination on breast cancer angiogenesis: dichotomus effect predictable by the HIFI alpha/VEGF pre-treatment status?

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2003, Anticancer research.

Autophagy and Bcl‐2/BNIP3 death regulatory pathway in non‐small cell lung carcinomas

E. Maltezos, A. Giatromanolaki, Demosthenes Bouros, 2013, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

C-erbB-2 oncoprotein expression in operable non-small cell lung cancer.

K. Gatter, V. Gorgoulis, C. Kittas, 1996, Anticancer research.

Depolarized expression of episialin (EMA, MUC1) in lung adenocarcinoma is associated with tumor progression.

G. Pruneri, A. Giatromanolaki, G. Coggi, 1998, Anticancer research.

Non-small cell lung cancer: c-erbB-2 overexpression correlates with low angiogenesis and poor prognosis.

K. Gatter, A. Giatromanolaki, M. Koukourakis, 1996, Anticancer research.

Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.

A. Harris, V. Georgoulias, K. Gatter, 2000, Cancer research.

‘Invading edge vs. inner’ (edvin) patterns of vascularization: an interplay between angiogenic and vascular survival factors defines the clinical behaviour of non‐small cell lung cancer

A. Harris, K. Gatter, A. Giatromanolaki, 2000, The Journal of pathology.

Tumour angiogenesis and response to radiotherapy.

M. Koukourakis, 2001, Anticancer research.

Loss of HLA-class-I expression in non-small-cell lung cancer: Association with prognosis and anaerobic metabolism.

A. Giatromanolaki, M. Koukourakis, Ioannis M. Koukourakis, 2022, Cellular immunology.

Autophagic flux response and glioblastoma sensitivity to radiation

A. Giatromanolaki, M. Koukourakis, S. Pouliliou, 2018, Cancer biology & medicine.

Autophagy and lysosomal related protein expression patterns in human glioblastoma

A. Harris, K. Gatter, A. Giatromanolaki, 2014, Cancer biology & therapy.

"Autophagic flux" in normal mouse tissues: Focus on endogenous LC3A processing

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, Autophagy.

“Stromatogenesis” and Tumor Progression

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2004, International journal of surgical pathology.

Hypofractionated Accelerated Chemo-radiotherapy (Chemo-HypoAR) With Cisplatin and Liposomal Doxorubicin for the Treatment of Patients With Uterine Sarcomas

M. Koukourakis, Ioannis M. Koukourakis, Spyros Domoxoudis, 2019, In Vivo.

The metabolic interactions between tumor cells and tumor-associated stroma (TAS) in prostatic cancer

S. Mendrinos, A. Giatromanolaki, M. Koukourakis, 2012, Cancer biology & therapy.

Repression of the autophagic response sensitises lung cancer cells to radiation and chemotherapy

Ilias V. Karagounis, A. Giatromanolaki, M. Koukourakis, 2016, British Journal of Cancer.

Evaluation of the Alamarblue Assay for Adherent Cell Irradiation Experiments

M. Koukourakis, C. Zois, Maria Zachari, 2014, Dose-response : a publication of International Hormesis Society.

Ectonucleotidase CD73 and CD39 expression in non-small cell lung cancer relates to hypoxia and immunosuppressive pathways.

A. Giatromanolaki, Aglaia Pappa, M. Koukourakis, 2020, Life sciences.

Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients

M. Koukourakis, A. Zissimopoulos*, V. Souftas, 2022, Radiation oncology journal.

Postmastectomy hypofractionated and accelerated radiation therapy with (and without) subcutaneous amifostine cytoprotection.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2013, International journal of radiation oncology, biology, physics.

Computed Tomography Assessment of Lung Density in Patients With Lung Cancer Treated With Accelerated Hypofractionated Radio-Chemotherapy Supported With Amifostine

M. Koukourakis, P. Tsoutsou, I. Abatzoglou, 2009, American journal of clinical oncology.

Hypofractionated accelerated radiochemotherapy with cytoprotection (Chemo-HypoARC) for inoperable non-small cell lung carcinoma.

Demosthenes Bouros, M. Koukourakis, G. Kyrgias, 2007, Anticancer research.

Prognostic and Predictive Relevance of Tumor-Infiltrating Lymphocytes in Squamous Cell Head–Neck Cancer Patients Treated with Radical Radiotherapy/Chemo-Radiotherapy

A. Giatromanolaki, M. Koukourakis, Ioannis M. Koukourakis, 2022, Current oncology.

Characterization of the "Autophagic Flux" in Prostate Cancer Tissue Biopsies by LC3A/LAMP2a Immunofluorescence and Confocal Microscopy.

A. Giatromanolaki, M. Koukourakis, D. Kalamida, 2019, Methods in molecular biology.

Vascular endothelial growth factor expression in non-small cell lung cancer.

K. O'Byrne, A. Giatromanolaki, M. Koukourakis, 2003, Methods in molecular medicine.

The presence of tumor-infiltrating FOXP3+ lymphocytes correlates with intratumoral angiogenesis in endometrial cancer.

A. Harris, A. Banham, K. Gatter, 2008, Gynecologic oncology.

Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis

A. Giatromanolaki, E. Kontomanolis, E. Efremidou, 2014, Medical Oncology.

LC3A-Positive “Stone-Like” Structures in Cutaneous Squamous Cell Carcinomas

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, The American Journal of dermatopathology.

Differential assessment of angiogenic activity and of vascular survival ability (VSA) in breast cancer

A. Harris, K. Gatter, C. Simopoulos, 2004, Clinical & Experimental Metastasis.

Regulatory tumor-infiltrating lymphocytes prevail in endometrial tumors with low vascular survival ability.

A. Giatromanolaki, E. Kontomanolis, M. Koukourakis, 2021, Immunobiology.

Rheumatoid nodules in thyroid gland parenchyma as an expression of rheumatoid arthritis: a case report

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2019, Journal of Medical Case Reports.

Fever-Range Hyperthermia vs. Hypothermia Effect on Cancer Cell Viability, Proliferation and HSP90 Expression

Ilias V. Karagounis, A. Giatromanolaki, M. Koukourakis, 2015, PloS one.

Inhibition of IKK-NFκB pathway sensitizes lung cancer cell lines to radiation

A. Giatromanolaki, M. Koukourakis, S. Pouliliou, 2017, Cancer biology & medicine.

Prognosis of Patients Correlated with Markers of Hypoxia / Acidity and with Poor Tumor-associated Stroma of Non-Small Cell Lung Cancer Is Enhanced Expression of SPARC / Osteonectin in the Updated Version

A. Harris, K. Gatter, A. Giatromanolaki, 2003 .

A Novel Lipofuscin-detecting Marker of Senescence Relates With Hypoxia, Dysregulated Autophagy and With Poor Prognosis in Non-small-cell-lung Cancer

A. Giatromanolaki, M. Koukourakis, M. Kouroupi, 2020, In Vivo.

Non-small cell lung cancer functional imaging: increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment.

A. Giatromanolaki, M. Koukourakis, S. Koukouraki, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Apalutamide radio-sensitisation of prostate cancer

A. Giatromanolaki, M. Koukourakis, D. Kalamida, 2021, British Journal of Cancer.

Coexpression of MUC 1 Glycoprotein with Multiple Angiogenic Factors in Non-Small Cell Lung Cancer Suggests Coactivation of Angiogenic and Migration Pathways 1

A. Harris, K. Gatter, A. Giatromanolaki, 2000 .

Structurally characterized copper-chrysin complexes display genotoxic and cytotoxic activity in human cells

D. Athanasiou, A. Pantazaki, M. Koukourakis, 2021 .

Concurrent liposomal cisplatin (Lipoplatin), 5-fluorouracil and radiotherapy for the treatment of locally advanced gastric cancer: a phase I/II study.

A. Giatromanolaki, T. Boulikas, M. Koukourakis, 2010, International journal of radiation oncology, biology, physics.

Radiochemotherapy with cetuximab, cisplatin, and amifostine for locally advanced head and neck cancer: a feasibility study.

M. Koukourakis, I. Karapantzos, P. Tsoutsou, 2010, International journal of radiation oncology, biology, physics.

Vascular endothelial growth factor (VEGF) expression in operable gallbladder carcinomas.

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2003, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Comparison of the effect of the antiandrogen apalutamide (ARN-509) versus bicalutamide on the androgen receptor pathway in prostate cancer cell lines

A. Giatromanolaki, M. Koukourakis, S. Pouliliou, 2018, Anti-cancer drugs.

FOXP3 infiltrating lymphocyte density and PD-L1 expression in operable non-small cell lung carcinoma

A. Harris, A. Banham, A. Giatromanolaki, 2019, Experimental lung research.

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

Mark R. Marten, Erinna F. Lee, Dana L. Miller, 2021, Autophagy.

Aldehyde dehydrogenase 3A1 promotes multi-modality resistance and alters gene expression profile in human breast adenocarcinoma MCF-7 cells.

R. Franco, A. Galanis, Aglaia Pappa, 2016, The international journal of biochemistry & cell biology.

Phosphorylated VEGFR2/KDR receptors are widely expressed in B‐cell non‐Hodgkin's lymphomas and correlate with hypoxia inducible factor activation

A. Harris, K. Gatter, A. Giatromanolaki, 2008, Hematological oncology.

Aldehyde dehydrogenase 3 A 1 promotes multimodality resistance and alters 1 gene expression profile in human breast adenocarcinoma MCF-7 cells 2 3

R. Franco, A. Galanis, Aglaia Pappa, 2016 .

Profiling of Aldehyde Dehydrogenase Isoforms in In Vitro Formed Tumorspheres

A. Giatromanolaki, Aglaia Pappa, G. Voulgaridou, 2021, AntiCancer Research.

Association of −634G/C and 936C/T polymorphisms of the vascular endothelial growth factor with spontaneous preterm delivery

E. Maltezos, D. Papazoglou, E. Kontomanolis, 2004, Acta obstetricia et gynecologica Scandinavica.

Vascular endothelial growth factor in inflammatory bowel disease

E. Maltezos, A. Giatromanolaki, M. Koukourakis, 2003, International Journal of Colorectal Disease.

Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?

C. Papadimitriou, A. Zygogianni, M. Koukourakis, 2022, Medical Oncology.

Amifostine administration during radiotherapy for cancer patients with genetic, autoimmune, metabolic and other diseases.

E. Maltezos, M. Koukourakis, 2006, Anti-cancer drugs.

Tracheal cancer treated with a short course of external and endoluminal radio-chemotherapy combined with cetuximab – a case report

M. Koukourakis, M. Froudarakis, I. Abatzoglou, 2010, Journal of contemporary brachytherapy.

LQ-based model for biological radiotherapy planning.

J. Damilakis, M. Koukourakis, 1994, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Angiogenic co‐operation of VEGF and stromal cell TP in endometrial carcinomas

A. Harris, K. Gatter, A. Giatromanolaki, 2002, The Journal of pathology.

Human Papillomavirus in Endometrial Adenocarcinomas: Infectious Agent or a Mere “Passenger”?

E. Maltezos, A. Giatromanolaki, D. Papazoglou, 2008, Infectious diseases in obstetrics and gynecology.

Increased expression of transcription factor EB (TFEB) is associated with autophagy, migratory phenotype and poor prognosis in non-small cell lung cancer.

A. Harris, K. Gatter, Ilias V. Karagounis, 2015, Lung cancer.

Increased glucose influx and glycogenesis in lung cancer cells surviving after irradiation

A. Giatromanolaki, M. Koukourakis, A. Tsolou, 2022, International journal of radiation biology.

Malignant retroperitoneal paraganglioma treated with concurrent radiotherapy and chemotherapy.

A. Tsaroucha, M. Koukourakis, M. Pitiakoudis, 2004, Clinical oncology (Royal College of Radiologists (Great Britain)).

The angiogenic “vascular endothelial growth factor/flk‐1(KDR) receptor” pathway in patients with endometrial carcinoma

A. Harris, K. Gatter, A. Giatromanolaki, 2001, Cancer.

Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises.

A. Giatromanolaki, Aglaia Pappa, I. Anestopoulos, 2022, Pharmacology & therapeutics.

Vascular endothelial growth factor gene polymorphisms and pre-eclampsia.

E. Maltezos, D. Papazoglou, E. Kontomanolis, 2004, Molecular human reproduction.

Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.

M. Koukourakis, E. Kouroumalis, A. Kapsoritakis, 2000 .

Elevated thrombopoietin serum levels in patients with inflammatory bowel disease

M. Koukourakis, E. Kouroumalis, A. Kapsoritakis, 2000, American Journal of Gastroenterology.

Expression of CD47 and SIRPα Macrophage Immune-Checkpoint Pathway in Non-Small-Cell Lung Cancer

A. Giatromanolaki, Aglaia Pappa, I. Anestopoulos, 2022, Cancers.

Radiotherapy alone for non-small cell lung carcinoma. Five-year disease-free survival and patterns of failure.

A. Giatromanolaki, M. Koukourakis, J. Skarlatos, 1995, Acta oncologica.

Computed Tomography (CT) Scan Evaluation of Late Toxicity Following Hypofractionated/Accelerated Radiotherapy With Cytoprotection (HypoARC) in Breast Cancer Patients Treated With Conservative Surgery

M. Koukourakis, Kyriaki Sismanidou, J. Manavis, 2006, American journal of clinical oncology.

Autophagy proteins in prostate cancer: relation with anaerobic metabolism and Gleason score.

S. Mendrinos, A. Giatromanolaki, M. Koukourakis, 2014, Urologic oncology.

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer.

A. Harris, K. O'Byrne, T. Ganesan, 1998, British Journal of Cancer.

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer

A. Harris, K. O'Byrne, J. Braybrooke, 1999, British Journal of Cancer.

Radical hypofractionated accelerated radiotherapy with cytoprotection for invasive bladder cancer.

M. Koukourakis, S. Touloupidis, C. Tsolos, 2007, Urology.

Blocking LDHA glycolytic pathway sensitizes glioblastoma cells to radiation and temozolomide.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2017, Biochemical and biophysical research communications.

LYVE-1 immunohistochemical assessment of lymphangiogenesis in endometrial and lung cancer

D. Jackson, C. Simopoulos, A. Giatromanolaki, 2005, Journal of Clinical Pathology.

Thymidine Phosphorylase Expression in Gallbladder Adenocarcinomas

A. Harris, K. Gatter, C. Simopoulos, 2002, International journal of surgical pathology.

Differential assessment of vascular survival ability and tumor angiogenic activity in colorectal cancer.

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Prognostic Role of Angiogenesis in Operable Carcinoma of the Gallbladder

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2002, American journal of clinical oncology.

Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2002, British Journal of Cancer.

Nuclear localization of human AP endonuclease 1 (HAP1/Ref‐1) associates with prognosis in early operable non‐small cell lung cancer (NSCLC)

A. Harris, K. Gatter, I. Hickson, 1999, The Journal of pathology.

Concurrent Hypofractionated Radiotherapy and 5-Fluorouracil for Advanced Sarcomas of the Bone

A. Giatromanolaki, M. Koukourakis, J. Skarlatos, 1998, Sarcoma.

Assessment of Radiobiological α/β Ratio in Lung Cancer and Fibroblast Cell Lines Using Viability Assays.

Ilias V. Karagounis, M. Koukourakis, E. Skourti, 2017, In vivo.

Hypofractionated/accelerated radiotherapy with cytoprotection (HypoARC) combined with vinorelbine and liposomal doxorubicin for locally advanced non-small cell lung cancer (NSCLC).

Demosthenes Bouros, M. Koukourakis, P. Tsoutsou, 2008, Anticancer research.

Interferon regulatory factor-1 (IRF-1) suppression and derepression during endometrial tumorigenesis and cancer progression.

A. Giatromanolaki, K. Mimidis, M. Koukourakis, 2004, Cytokine.

Individualization of the subcutaneous amifostine dose during hypofractionated / accelerated radiotherapy.

M. Koukourakis, I. Abatzoglou, Leonidas Sivridis, 2006, Anticancer research.

A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma

R. Crevoisier, J. Bourhis, V. Georgoulias, 2001 .

Lung cancer: An organized cellular and metabolic domain

A. Giatromanolaki, G. Bougioukas, M. Koukourakis, 2007 .

Radio-Immunotherapy: A Case Report of ‘Abscopal Hyper-Progression’?

M. Koukourakis, V. Kouloulias, Ioannis M. Koukourakis, 2020, Cureus.

Predicting Distant Failure in Nasopharyngeal Cancer

A. Giatromanolaki, M. Koukourakis, R. Whitehouse, 1996, The Laryngoscope.

iNOS Expression by Tumor-Infiltrating Lymphocytes, PD-L1 and Prognosis in Non-Small-Cell Lung Cancer

A. Giatromanolaki, K. Chlichlia, M. Koukourakis, 2020, Cancers.

Narrow amifostine dose windows define radioprotection outcome, following fractionated whole-body irradiation of mice.

C. Simopoulos, A. Giatromanolaki, M. Koukourakis, 2011, In vivo.

Amifostine protects lymphocytes during radiotherapy and stimulates expansion of the CD95/Fas and CD31 expressing T-cells, in breast cancer patients

M. Koukourakis, G. Bourikas, C. Tsatalas, 2003, Cancer Immunology, Immunotherapy.

Treatment of low-risk prostate cancer with radical hypofractionated accelerated radiotherapy with cytoprotection (HypoARC): an interim analysis of toxicity and efficacy.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, Anticancer research.

Conformal hypofractionated and accelerated radiotherapy with cytoprotection (HypoARC) for high risk prostatic carcinoma: rationale, technique and early experience.

M. Koukourakis, S. Touloupidis, I. Abatzoglou, 2004, Anticancer research.

Trachycladines and Analogues: Synthesis and Evaluation of Anticancer Activity

M. Koukourakis, Alexandros E. Koumbis, A. E. Koumbis, 2017, ChemMedChem.

Amifostine Protects Mouse Liver Against Radiation-induced Autophagy Blockage.

A. Harris, D. Ferguson, Ilias V. Karagounis, 2018, Anticancer research.

Concurrent administration of liposomal doxorubicin improves the survival of patients with invasive bladder cancer undergoing hypofractionated accelerated radiotherapy (HypoARC)

A. Giatromanolaki, M. Koukourakis, C. Kalaitzis, 2011, Medical oncology.

Different patterns of stromal and cancer cell thymidine phosphorylase reactivity in non-small-cell lung cancer: impact on tumour neoangiogenesis and survival.

K. O'Byrne, A. Giatromanolaki, M. Koukourakis, 1998, British Journal of Cancer.

Thymidine phosphorylase expression in endometrial carcinomas

A. Harris, K. Gatter, A. Giatromanolaki, 1999, Clinical & Experimental Metastasis.

Platelet‐derived endothelial cell growth factor (Thymidine Phosphorylase) expression in lung cancer

A. Harris, K. O'Byrne, K. Gatter, 1997, The Journal of pathology.

BNIP3 expression in endometrial cancer relates to active hypoxia inducible factor 1α pathway and prognosis

A. Harris, K. Gatter, A. Giatromanolaki, 2007, Journal of Clinical Pathology.

Treatment of invasive bladder cancer with conformal hypofractionated accelerated radiotherapy and amifostine (HypoARC).

A. Giatromanolaki, M. Koukourakis, S. Touloupidis, 2012, Urologic oncology.

Clinical and experimental evidence of Bcl-2 involvement in the response to photodynamic therapy.

A. Giatromanolaki, M. Koukourakis, L. Corti, 2001, Anticancer research.

Angiogenesis and vascular survival ability in ovarian adenocarcinomas

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2004, Virchows Archiv.

SMER28 is a mTOR-independent small molecule enhancer of autophagy that protects mouse bone marrow and liver against radiotherapy

A. Harris, D. Ferguson, Ilias V. Karagounis, 2018, Investigational New Drugs.

Induction of thymidine phosphorylase as a pharmacodynamic end-point in patients with advanced carcinoma treated with 5-fluorouracil, folinic acid and interferon alpha

A. Harris, K. O'Byrne, T. Ganesan, 2000, British Journal of Cancer.

Programmed death-1 receptor (PD-1) and PD-ligand-1 (PD-L1) expression in non-small cell lung cancer and the immune-suppressive effect of anaerobic glycolysis

A. Harris, A. Giatromanolaki, M. Koukourakis, 2019, Medical Oncology.

Angiogenesis in ductal breast carcinoma. Comparison of microvessel density between primary tumour and lymph node metastasis.

A. Harris, A. Giatromanolaki, M. Koukourakis, 1999, Cancer letters.

Assessment and management of cutaneous reactions with amifostine administration: findings of the ethyol (amifostine) cutaneous treatment advisory panel (ECTAP).

J. Bourhis, D. Brizel, M. Turner, 2004, International journal of radiation oncology, biology, physics.

Autophagy patterns and prognosis in uveal melanomas

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, Modern Pathology.

Lactate Dehydrogenase 5 Expression in Squamous Cell Head and Neck Cancer Relates to Prognosis following Radical or Postoperative Radiotherapy

A. Harris, A. Giatromanolaki, M. Koukourakis, 2009, Oncology.

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

K. O'Byrne, A. Giatromanolaki, H. Turley, 2000, British Journal of Cancer.

c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.

A. Giatromanolaki, G. Fountzilas, M. Koukourakis, 2000, Anticancer research.

Autophagosome Proteins LC3A, LC3B and LC3C Have Distinct Subcellular Distribution Kinetics and Expression in Cancer Cell Lines

A. Harris, K. Gatter, A. Giatromanolaki, 2015, PloS one.

Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small-cell lung cancer.

K. O'Byrne, D. Talbot, A. Giatromanolaki, 1997, British Journal of Cancer.

Dose Escalation of Amifostine for Radioprotection During Pelvic Accelerated Radiotherapy

M. Koukourakis, G. Kyrgias, A. Papadopoulou, 2013, American journal of clinical oncology.

Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preventing radiation induced xerostomia.

M. Koukourakis, V. Danielidis, 2005, Cancer treatment reviews.

Amifostine: is there evidence of tumor protection?

M. Koukourakis, Michael I Koukourakis, 2003, Seminars in oncology.

Radiation damage and radioprotectants: new concepts in the era of molecular medicine.

M. Koukourakis, M I Koukourakis, 2012, The British journal of radiology.

Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration

A. Harris, A. Banham, A. Giatromanolaki, 2020, British Journal of Cancer.

HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite.

V. Nizet, J. Blackwell, A. Giatromanolaki, 2007, Blood.

Radiation pneumonitis and fibrosis: mechanisms underlying its pathogenesis and implications for future research.

M. Koukourakis, P. Tsoutsou, 2006, International journal of radiation oncology, biology, physics.

Hypoxia inducible factor (HIF-1a and HIF-2a) expression in early esophageal cancer and response to photodynamic therapy and radiotherapy.

A. Harris, K. Gatter, A. Giatromanolaki, 2001, Cancer research.

DEC1 (STRA13) protein expression relates to hypoxia‐ inducible factor 1‐alpha and carbonic anhydrase‐9 overexpression in non‐small cell lung cancer

Charles C Wykoff, Adrian L Harris, A. Harris, 2003, The Journal of pathology.

'Stemness' and 'senescence' related escape pathways are dose dependent in lung cancer cells surviving post irradiation.

A. Giatromanolaki, M. Koukourakis, A. Tsolou, 2019, Life sciences.

Tumor draining lymph nodes, immune response, and radiotherapy: Towards a revisal of therapeutic principles.

A. Giatromanolaki, M. Koukourakis, 2022, Biochimica et biophysica acta. Reviews on cancer.

Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head–neck cancer

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2012, British Journal of Cancer.

Relation of hypoxia inducible factor 1α and 2α in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival

A. Harris, K. Gatter, A. Giatromanolaki, 2001, British Journal of Cancer.

Comparison of metabolic pathways between cancer cells and stromal cells in colorectal carcinomas: a metabolic survival role for tumor-associated stroma.

Adrian L Harris, A. Harris, A. Giatromanolaki, 2006, Cancer research.

High Beclin 1 expression defines a poor prognosis in endometrial adenocarcinomas.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, Gynecologic oncology.

Amifostine enhances recovery and expansion of peripheral FAS/CD95+ T- and NK-cell subpopulations during radiotherapy of patients with head-neck cancer

E. Maltezos, M. Koukourakis, A. Gritzapis, 2009, International journal of radiation biology.

forming microsatellite - the macrophage immune response gene SLC11A1 from a Z-DNA HIF-1 regulates heritable variation and allele expression phenotypes of

V. Nizet, A. Giatromanolaki, R. Johnson, 2013 .

Autophagy in endometrial carcinomas and prognostic relevance of 'stone-like' structures (SLS): What is destined for the atypical endometrial hyperplasia?

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, Autophagy.

Phosphorylated KDR expression in endometrial cancer cells relates to HIF1α/VEGF pathway and unfavourable prognosis

Adrian L Harris, A. Harris, K. Gatter, 2006, Modern Pathology.

Lung cancer: a comparative study of metabolism related protein expression in cancer cells and tumor associated stroma.

A. Giatromanolaki, G. Bougioukas, M. Koukourakis, 2007, Cancer biology & therapy.

Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2017, Experimental lung research.

Hypoxia-inducible factor (HIF1A and HIF2A), angiogenesis, and chemoradiotherapy outcome of squamous cell head-and-neck cancer.

A. Harris, K. Gatter, C. Simopoulos, 2002, International journal of radiation oncology, biology, physics.

Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients.

E Helene Sage, Adrian L Harris, A. Harris, 2003, Cancer research.

The pathology of tumor stromatogenesis

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2007, Cancer biology & therapy.

Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.

A. Harris, K. Gatter, A. Giatromanolaki, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2005, Clinical & Experimental Metastasis.

Liposomal doxorubicin and conventionally fractionated radiotherapy in the treatment of locally advanced non-small-cell lung cancer and head and neck cancer.

A. Giatromanolaki, M. Koukourakis, S. Koukouraki, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lactate dehydrogenase 5 expression in non-Hodgkin B-cell lymphomas is associated with hypoxia regulated proteins

A. Harris, K. Gatter, A. Giatromanolaki, 2008, Leukemia & lymphoma.

Angiogenesis in Colorectal Cancer: Prognostic and Therapeutic Implications

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2006, American journal of clinical oncology.

Oral administration of recombinant human granulocyte macrophage colony-stimulating factor in the management of radiotherapy-induced esophagitis.

A. Giatromanolaki, C. Flordellis, M. Koukourakis, 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

The vascular network of tumours — what is it not for?

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2003, The Journal of pathology.

PROGNOSTIC VALUE OF ANGIOGENESIS IN OPERABLE NON‐SMALL CELL LUNG CANCER

A. Harris, D. Talbot, K. Gatter, 1996, The Journal of pathology.

Exploring the Molecular Determinants of Tumor-Stroma Interaction in Non-small Cell Lung Cancer Through the Utilization of RNA-seq Data from Lung Biopsies

Ilias Maglogiannis, A. Chatziioannou, A. Giatromanolaki, 2016 .

Inclusion of Vasculature-Related Variables in the Dukes Staging System of Colon Cancer

A. Harris, K. Gatter, A. Giatromanolaki, 2005, Clinical Cancer Research.

Combined role of tumor angiogenesis, bcl‐2, and p53 expression in the prognosis of patients with colorectal carcinoma

A. Harris, K. Gatter, A. Giatromanolaki, 1999, Cancer.

Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy

A. Harris, G. Folprecht, K. Gatter, 2011, Clinical Cancer Research.

Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer

A. Giatromanolaki, M. Koukourakis, M. Katotomichelakis, 2022, Head and Neck Pathology.

High intratumoural accumulation of stealth® liposomal doxorubicin (Caelyx®) in glioblastomas and in metastatic brain tumours

N. Kelekis, M. Koukourakis, S. Koukouraki, 2000, British Journal of Cancer.

Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

External beam radiotherapy for prostate cancer: current position and trends.

M. Koukourakis, S. Touloupidis, 2006, Anticancer research.

Optimal timing for adjuvant radiation therapy in breast cancer: a comprehensive review and perspectives.

M. Koukourakis, Y. Belkacemi, D. Azria, 2009, Critical reviews in oncology/hematology.

Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.

A. Giatromanolaki, F. Pezzella, H. Turley, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Tumor specific activation of the VEGF/KDR angiogenic pathway in a subset of locally advanced squamous cell head and neck carcinomas

A. Harris, K. Gatter, A. Giatromanolaki, 2004, Clinical & Experimental Metastasis.

Nuclear expression of human apurinic/apyrimidinic endonuclease (HAP1/Ref-1) in head-and-neck cancer is associated with resistance to chemoradiotherapy and poor outcome.

K. Gatter, I. Hickson, A. Giatromanolaki, 2001, International journal of radiation oncology, biology, physics.

Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.

A. Giatromanolaki, G. Fountzilas, M. Koukourakis, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2006, Breast.

Low-Dose Radiotherapy for Late-Stage COVID-19 Pneumonia?

M. Koukourakis, 2020, Dose-response : a publication of International Hormesis Society.

Carbonic anhydrase 9 (CA9) expression in non-small-cell lung cancer: correlation with regulatory FOXP3+T-cell tumour stroma infiltration

A. Banham, A. Giatromanolaki, M. Koukourakis, 2020, British Journal of Cancer.

Technical Note: Partial body irradiation of mice using a customized PMMA apparatus and a clinical 3D planning/LINAC radiotherapy system.

Ilias V. Karagounis, M. Koukourakis, I. Abatzoglou, 2016, Medical physics.

MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.

A. Harris, K. Gatter, A. Giatromanolaki, 1998, Journal of clinical pathology.

Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine

A. Giatromanolaki, M. Koukourakis, I. Karakasiliotis, 2021, Medical Oncology.

Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve

A. Giatromanolaki, M. Koukourakis, A. Mitrakas, 2016, British Journal of Cancer.

Intensified autophagy compromises the efficacy of radiotherapy against prostate cancer.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2015, Biochemical and biophysical research communications.

Important Role of Autophagy in Endothelial Cell Response to Ionizing Radiation

Ilias V. Karagounis, A. Giatromanolaki, M. Koukourakis, 2014, PloS one.

Beclin-1 and LC3A expression in cutaneous malignant melanomas: a biphasic survival pattern for beclin-1

S. Mendrinos, A. Giatromanolaki, M. Koukourakis, 2011, Melanoma research.

Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2010, British Journal of Cancer.

LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas.

A. Harris, D. Ferguson, K. Gatter, 2010, The American journal of pathology.

Warburg effect, lactate dehydrogenase, and radio/chemo-therapy efficacy

A. Giatromanolaki, M. Koukourakis, 2018, International journal of radiation biology.

Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.

A. Harris, C. Wykoff, J. Pastorek, 2001, Cancer research.

Rectal cancer induces a regulatory lymphocytic phenotype in the tumor-draining lymph nodes to promote cancer cell installation

A. Giatromanolaki, M. Koukourakis, M. Kouroupi, 2020, Immunologic Research.

Aldehyde Dehydrogenase 1B1 Is Associated with Altered Cell Morphology, Proliferation, Migration and Chemosensitivity in Human Colorectal Adenocarcinoma Cells

A. Giatromanolaki, Aglaia Pappa, G. Voulgaridou, 2021, Biomedicines.

Angiogenesis and Bone Metastasis: Implications for Diagnosis, Prevention and Treatment

M. Koukourakis, P. Tsoutsou, 2009 .

Cutaneous squamous-cell carcinoma of the head-neck area refractory to chemo-radiotherapy: benefit from anti-PD-1 immunotherapy

A. Giatromanolaki, M. Koukourakis, M. Kouroupi, 2021, BJR case reports.

Lactate dehydrogenase 5 (LDH-5) expression in endometrial cancer relates to the activated VEGF/VEGFR2(KDR) pathway and prognosis.

A. Harris, K. Gatter, A. Giatromanolaki, 2006, Gynecologic oncology.

Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis

A. Giatromanolaki, G. Bougioukas, M. Koukourakis, 2003, British Journal of Cancer.

Potential role of bcl‐2 as a suppressor of tumour angiogenesis in non‐small‐cell lung cancer

A. Harris, K. O'Byrne, D. Talbot, 1997, International journal of cancer.

Optimal sequence of implied modalities in the adjuvant setting of breast cancer treatment: an update on issues to consider.

A. Kuten, J. Gligorov, M. Koukourakis, 2010, The oncologist.

LC3A, LC3B and Beclin-1 Expression in Gastric Cancer

A. Giatromanolaki, I. Georgiou, M. Koukourakis, 2018, AntiCancer Research.

Patterns of autophagy in urothelial cell carcinomas--the significance of "stone-like" structures (SLS) in transurethral resection biopsies.

S. Mendrinos, A. Giatromanolaki, M. Koukourakis, 2013, Urologic oncology.

LC3 immunostaining pitfalls

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2013, Histopathology.

Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.

A. Giatromanolaki, G. Fountzilas, M. Koukourakis, 2001, Anticancer research.

p53 and angiogenesis in non-small-cell lung cancer.

A. Giatromanolaki, M. Koukourakis, 1998, British Journal of Cancer.

“An RNA-seq analysis from non-small cell lung cancer biopsies suggests an important role for aberrant alternative splicing in its pathophysiology”

Ilias Maglogiannis, A. Giatromanolaki, A. Chatziioannou, 2017 .

Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis

E. Maltezos, A. Harris, K. Gatter, 2003, Arthritis research & therapy.

Lymphopenia and intratumoral lymphocytic balance in the era of cancer Immuno-Radiotherapy.

A. Giatromanolaki, M. Koukourakis, 2021, Critical reviews in oncology/hematology.

Hypofractionated radiotherapy with 5-fluorouracil radiosensitization for locally "far advanced" breast cancer.

M. Koukourakis, A. Ardavanis, J. Skarlatos, 1997, American journal of clinical oncology.

Cancer vascularization: implications in radiotherapy?

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2000, International journal of radiation oncology, biology, physics.

Transurethral radiotherapy for benign prostatic hypertrophy-related urethral obstruction. Dosimetry, ethics, and preliminary results.

M. Koukourakis, I. Stamatelatos, J. Skarlatos, 1994, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Successful Treatment of a Locally Recurrent and Metastatic Malignant Phyllodes Tumor with Accelerated Radiotherapy and Nab-Paclitaxel, Cisplatin, and Liposomal Doxorubicin Chemotherapy

V. Kouloulias, A. Zygogianni, M. Koukourakis, 2021, Chemotherapy.

CT-based radiotherapy treatment planning for cancer of the nasopharynx.

M. Koukourakis, E. Helidonis, H. Varveris, 1993, Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society.

Squamous cell nose and a synchronous in-situ vocal cord carcinoma: a case report.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2007, B-ENT.

Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.

A. Harris, C. Wykoff, J. Pastorek, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Serum and Tissue LDH Levels in Patients with Breast/Gynaecological Cancer and Benign Diseases

A. Giatromanolaki, E. Kontomanolis, M. Koukourakis, 2008, Gynecologic and Obstetric Investigation.

Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab

A. Harris, A. Giatromanolaki, F. Buffa, 2009, Clinical Cancer Research.

Tumor microenvironment, immune response and post-radiotherapy tumor clearance

A. Giatromanolaki, M. Koukourakis, 2020, Clinical and Translational Oncology.

Cytoprotective activity of amifostine on cultured human lymphocytes exposed to irinotecan.

F. Papachristou, M. Koukourakis, D. Kareli, 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

The prognostic and therapeutic implications of distinct patterns of argininosuccinate synthase 1 (ASS1) and arginase-2 (ARG2) expression by cancer cells and tumor stroma in non-small-cell lung cancer

A. Harris, A. Giatromanolaki, M. Koukourakis, 2021, Cancer & Metabolism.

bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer

Barbara Krammer, Adrian L. Harris, A. Harris, 2004, Clinical & Experimental Metastasis.

Effect of mitochondrial metabolism-interfering agents on cancer cell mitochondrial function and radio/chemosensitivity

M. Koukourakis, D. Kalamida, A. Mitrakas, 2014, Anti-cancer drugs.

Association of hypoxia‐inducible factors 1α and 2α with activated angiogenic pathways and prognosis in patients with endometrial carcinoma

Adrian L. Harris, A. Harris, K. Gatter, 2002 .

A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix.

M. Koukourakis, H. Varveris, E. Koumantakis, 1998, The British journal of radiology.

Reduction of the radiation dose received by interventional cardiologists following training in radiation protection.

M. Koukourakis, S. Konstantinides, I. Abatzoglou, 2013, Radiation protection dosimetry.

Coexpression of MUC1 glycoprotein with multiple angiogenic factors in non-small cell lung cancer suggests coactivation of angiogenic and migration pathways.

K. Gatter, A. Giatromanolaki, M. Koukourakis, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

CYP17A1 and Androgen-Receptor Expression in Prostate Carcinoma Tissues and Cancer Cell Lines

A. Giatromanolaki, M. Koukourakis, T. Lialiaris, 2019, Current Urology.

Tumor Microenvironment and Immune Response in Lip Cancer

A. Giatromanolaki, M. Koukourakis, M. Lambropoulou, 2023, Cancers.

Hypoxia-Inducible Factor-2α (HIF-2α) Induces Angiogenesis in Breast Carcinomas

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2006, Applied immunohistochemistry & molecular morphology : AIMM.

Is anti-PD-1 immunotherapy a means for post-irradiation tumor clearance in head and neck cancer?

C. Papadimitriou, A. Zygogianni, M. Koukourakis, 2022, Medical Oncology.

Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance.

A. Harris, A. Giatromanolaki, M. Koukourakis, 1996, British Journal of Cancer.

Expression of prolyl-hydroxylases PHD-1, 2 and 3 and of the asparagine hydroxylase FIH in non-small cell lung cancer relates to an activated HIF pathway.

A. Harris, K. Gatter, A. Giatromanolaki, 2008, Cancer letters.

Survival Fraction at 2 Gy and γH2AX Expression Kinetics in Peripheral Blood Lymphocytes From Cancer Patients: Relationship With Acute Radiation-Induced Toxicities.

Aglaia Pappa, A. Giatromanolaki, D. Papazoglou, 2015, International journal of radiation oncology, biology, physics.

Lactate Dehydrogenase Isoenzymes 1 and 5: Differential Expression by Neoplastic and Stromal Cells in Non-Small Cell Lung Cancer and Other Epithelial Malignant Tumors

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2003, Tumor Biology.

Biological dose volume histograms during conformal hypofractionated accelerated radiotherapy for prostate cancer.

M. Koukourakis, S. Touloupidis, I. Abatzoglou, 2006, Medical physics.

Molecular analysis of local relapse in high-risk breast cancer patients: can radiotherapy fractionation and time factors make a difference?

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2003, British Journal of Cancer.

Hypofractionated and accelerated radiotherapy with amifostine cytoprotection (HypoARC): a new concept in radiotherapy and encouraging results in breast cancer.

M. Koukourakis, 2002, Seminars in oncology.

Effect of amifostine on response rates in locally advanced non-small-cell lung cancer patients treated on randomized controlled trials: a meta-analysis.

R. Komaki, L. Mell, A. Mundt, 2007, International journal of radiation oncology, biology, physics.

Concurrent conventionally factionated radiotherapy and weekly docetaxel in the treatment of stage IIIb non-small-cell lung carcinoma

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 1999, British Journal of Cancer.

High Dose Hyperfractionated Radiotherapy for Adults with Glioblastomas.

M. Koukourakis, J. Scarlatos, N. Kordiolis, 2015, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Hypofractionated Accelerated Radiotherapy With Cytoprotection Combined With Trastuzumab, Liposomal Doxorubicine, and Docetaxel in c-erbB-2–Positive Breast Cancer

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2005, American journal of clinical oncology.

High dose hyperfractionated radiotherapy for adults with glioblastomas.

M. Koukourakis, J. Scarlatos, N. Kordiolis, 1993, Medical dosimetry : official journal of the American Association of Medical Dosimetrists.

Weekly docetaxel and concomitant boost radiotherapy for non-small cell lung cancer. A phase I/II dose escalation trial.

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 1998, European journal of cancer.

c-erbB-2 and the “triple-state” in early breast carcinomas

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2010, Medical oncology.

The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma.

J. Damilakis, A. Giatromanolaki, M. Koukourakis, 1996, International journal of radiation oncology, biology, physics.

Endogenous markers of hypoxia/anaerobic metabolism and anemia in primary colorectal cancer

A. Harris, K. Gatter, A. Giatromanolaki, 2006, Cancer science.

BNIP3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non–Small Cell Lung Cancer

A. Harris, K. Gatter, A. Giatromanolaki, 2004, Clinical Cancer Research.

Normal tissue radioprotection by amifostine via Warburg-type effects

A. Harris, Ilias V. Karagounis, A. Giatromanolaki, 2016, Scientific Reports.

A pilot study on plasma levels of micro-RNAs involved in angiogenesis and vascular maturation in patients with breast cancer

A. Giatromanolaki, E. Kontomanolis, M. Koukourakis, 2017, Medical Oncology.

The CD44+/CD24− phenotype relates to ‘triple-negative’ state and unfavorable prognosis in breast cancer patients

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, Medical oncology.

Hypoxia inducible factor 1alpha and 2alpha overexpression in inflammatory bowel disease.

E. Maltezos, C. Simopoulos, A. Giatromanolaki, 2003, Journal of clinical pathology.

p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.

A. Giatromanolaki, G. Fountzilas, M. Koukourakis, 1998, Anticancer research.

Oxygen and glucose consumption in gastrointestinal adenocarcinomas: Correlation with markers of hypoxia, acidity and anaerobic glycolysis

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2006, Cancer science.

Tertiary Lymphoid Structures, Immune Response, and Prognostic Relevance in Non-Small Cell Lung Cancer

A. Giatromanolaki, M. Koukourakis, Constantinos A. Contrafouris, 2022, Cancer investigation.

Increased Soluble PD-L1 Levels in the Plasma of Patients with Epithelial Ovarian Cancer Correlate with Plasma Levels of miR34a and miR200

A. Giatromanolaki, E. Kontomanolis, M. Koukourakis, 2018, AntiCancer Research.

Hypoxia and acidity regulate immune checkpoint molecule and IFN-β expression in non-small cell lung cancer cell lines

A. Giatromanolaki, M. Koukourakis, A. Mitrakas, 2023, Journal of receptor and signal transduction research.

Intratumoral angiogenesis: a new prognostic indicator for stage I endometrial adenocarcinomas?

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 1999, Oncology research.

Endogenous markers of two separate hypoxia response pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase 9) are associated with radiotherapy failure in head and neck cancer patients recruited in the CHART randomized trial.

A. Harris, G. Wilson, F. Daley, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neo-angiogenesis in locally advanced squamous cell head and neck cancer correlates with thymidine phosphorylase expression and p53 nuclear oncoprotein accumulation

A. Harris, K. Gatter, A. Giatromanolaki, 1998, Clinical & Experimental Metastasis.

Focal expression of thymidine phosphorylase associates with CD31 positive lymphocytic aggregation and local neo-angiogenesis in non-small cell lung cancer.

K. O'Byrne, A. Giatromanolaki, M. Koukourakis, 1998, Anticancer research.

Bcl-2 and p53 expression in stage I endometrial carcinoma.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 1998, Anticancer research.

Postoperative Accelerated Radiotherapy with Cytoprotection Followed by Three-Dimensional Conformal Boost in Patients with Early Endometrial/Cervical Cancer

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2009 .

Postoperative accelerated radiotherapy with cytoprotection followed by three-dimensional conformal boost in patients with early endometrial/cervical cancer.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2009, Tumori.

Lactate dehydrogenase 5 isoenzyme overexpression defines resistance of prostate cancer to radiotherapy

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2014, British Journal of Cancer.

BNIP 3 Expression Is Linked with Hypoxia-Regulated Protein Expression and with Poor Prognosis in Non – Small Cell Lung Cancer

A. Harris, K. Gatter, A. Giatromanolaki, 2004 .

Bevacizumab, capecitabine, amifostine, and preoperative hypofractionated accelerated radiotherapy (HypoArc) for rectal cancer: a Phase II study.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, International journal of radiation oncology, biology, physics.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2011, American journal of clinical oncology.

Unresectable colorectal-carcinoma - 10 years experience with patients treated with radical or palliative external-beam radiotherapy in Greece.

N. Gourtsoyiannis, M. Koukourakis, G. Pissakas, 1994, Oncology reports.

Squamous cell head and neck cancer: evidence of angiogenic regeneration during radiotherapy.

A. Harris, K. Gatter, A. Giatromanolaki, 2001, Anticancer research.

Thermogenic protein UCP1 and UCP3 expression in non-small cell lung cancer: relation with glycolysis and anaerobic metabolism

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2017, Cancer biology & medicine.

Long-term survival of a patient with multiple abdominal metastasis from endometrial carcinoma treated with multi-portal conformal re-irradiation and chemotherapy.

M. Koukourakis, G. Kyrgias, A. Papadopoulou, 2011, Hematology/oncology and stem cell therapy.

Outcome of patients receiving photodynamic therapy for early esophageal cancer.

A. Giatromanolaki, M. Koukourakis, L. Corti, 2000, International journal of radiation oncology, biology, physics.

Hypoxia-inducible proteins HIF1α and lactate dehydrogenase LDH5, key markers of anaerobic metabolism, relate with stem cell markers and poor post-radiotherapy outcome in bladder cancer

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2016, International journal of radiation biology.

Combined irinotecan, docetaxel and conventionally fractionated radiotherapy in locally advanced head and neck cancer. A phase I dose escalation study.

A. Giatromanolaki, M. Koukourakis, C. Papadakis, 1999, Anticancer research.

Is Locally Advanced Head-Neck Cancer One More Candidate for Accelerated Hypofractionation?

V. Kouloulias, A. Zygogianni, M. Koukourakis, 2021, Anticancer Research.

Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

Sara W. Bird, Erinna F. Lee, Michael D. Kim, 2016 .

Long-Term Results of Postoperative Hypofractionated Accelerated Breast and Lymph Node Radiotherapy (HypoAR) with Hypofractionated Boost

A. Giatromanolaki, M. Koukourakis, I. Abatzoglou, 2021, Current oncology.

Linguistic validation of the Greek M.D. Anderson Symptom Inventory - Head and Neck Module.

C. Cleeland, T. Mendoza, D. Rosenthal, 2012, Forum of clinical oncology.

Metabolic cooperation between co-cultured lung cancer cells and lung fibroblasts

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2017, Laboratory Investigation.

Hypoxia inducible factor (HIF1α and HIF2α) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2008, International journal of radiation biology.

V, Gatter KC, Harris AL, Koukourakis MI. Combined Role of Tumor Angiogenesis, bcl-2, and p53 Expression in the Prognosis of Patients With Colorectal Carcinoma. Cancer. 1999;86:1421-30

A. Harris, K. Gatter, C. Papadimitriou, 2009 .

Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652

Lee, Duchen, Izzo, 2016 .

Histological changes after radiation therapy in patients with lung cancer: a prospective study.

A. Giatromanolaki, Demosthenes Bouros, M. Koukourakis, 2014, Anticancer research.

Colorectal Cancer: Lactate Dehydrogenase (LDH) Activity as a Prognostic Marker

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2009 .

Establishment and validation of a method for multi-dose irradiation of cells in 96-well microplates.

M. Koukourakis, C. Zois, S. Pouliliou, 2013, Biochemical and biophysical research communications.

Phosphorylated pVEGFR2/KDR receptor expression in uveal melanomas: relation with HIF2α and survival

A. Harris, K. Gatter, A. Giatromanolaki, 2011, Clinical & Experimental Metastasis.

Subcutaneous amifostin during fractionated radiotherapy: a randomized phase II study in pelvic tumours

M. Koukourakis, A. Stavroulaki, C. Frangiadaki, 1999 .

177 Subcutaneous amifostine during fractionated radiotherapy for lung, pelvic and head and neck cancer: A randomized phase II study

V. Georgoulias, A. Giatromanolaki, M. Koukourakis, 1999 .

Triplet chemotherapy with docetaxel, gemcitabine and liposomal doxorubicin, supported with subcutaneous amifostine and hemopoietic growth factors, in advanced non-small cell lung cancer.

Demosthenes Bouros, M. Koukourakis, George Patlakas, 2005, Anticancer research.

Using Liquid Biopsy to Predict Relapse After Radiotherapy in Squamous Cell Head-Neck and Esophageal Cancer.

M. Koukourakis, Ioannis M. Koukourakis, Erasmia T. Xanthopoulou, 2023, Cancer diagnosis & prognosis.

Irradiation-induced IFN-type-I pathway activation in prostate cancer cell lines.

A. Giatromanolaki, M. Koukourakis, C. Kalaitzis, 2023, Cytokine.

Metastatic Mucinous Adenocarcinoma of the Prostate with PSA Value of 8.6 ng/mL at 5-Year-Followup after Prostatectomy, Radiotherapy, and Androgen Deprivation

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2014, Case Reports in Urology.

Early Antivascular Effects of Bevacizumab Anti-VEGF Monoclonal Antibody on Colorectal Carcinomas Assessed With Functional CT Imaging

M. Koukourakis, C. Manolas, G. Minopoulos, 2007, American journal of clinical oncology.

Angiogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer.

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2000, Oncology research.

The role of 99mTc-sestamibi scintimammography and colour Doppler ultrasonography in the evaluation of breast lesions

D. Tsiftsis, M. Koukourakis, S. Koukouraki, 2001, Nuclear medicine communications.

Angiogenesis and Apoptosis‐Related Protein (p53, bcl‐2, and bax) Expression Versus Response of Gastric Adenocarcinomas to Paclitaxel and Carboplatin Chemotherapy

C. Kittas, A. Giatromanolaki, G. Fountzilas, 2001, American journal of clinical oncology.

Expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref‐1) protein: a basis for its role in human disease

Harris, A. Harris, I. Hickson, 1998, Histopathology.

Hypoxia Inducible Factor Expression and Angiogenesis - Analysis in the Pituitary Gland and Patterns of Death.

A. Giatromanolaki, D. Papazoglou, M. Koukourakis, 2018, In vivo.

Amifostine before chemotherapy: improved tolerance profile of the subcutaneous over the intravenous route.

M. Koukourakis, C. Manolas, G. Minopoulos, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC)

A. Harris, K. Gatter, A. Giatromanolaki, 2013, Angiogenesis.

P. Pavlidis, A. Tsaroucha, A. Giatromanolaki, 2022, International journal of radiation oncology, biology, physics.

839 Hypoxia-inducible factors 1a and 2a in skin malignant melanomas

A. Harris, K. Gatter, A. Giatromanolaki, 2003 .

Endometrial carcinoma: association of steroid hormone receptor expression with low angiogenesis and bcl-2 expression

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2001, Virchows Archiv.

Anti-PD-1 immunotherapy with dose-adjusted ultra-hypofractionated re-irradiation in patients with locoregionally recurrent head and neck cancer

M. Koukourakis, Ioannis M. Koukourakis, Axiotis G. Giakzidis, 2023, Clinical and Translational Oncology.

Radio-Immunotherapy: A Case Report of 'Abscopal Hyper-Progression'?

M. Koukourakis, V. Kouloulias, Ioannis M. Koukourakis, 2020 .

Long‐Term survival of patients treated with photodynamic therapy for carcinoma in situ and early non‐small‐cell lung carcinoma

Luigi Corti, Lamberto Toniolo, Flavio Colaut, 2007, Lasers in surgery and medicine.

Relationship of vascular maturation in breast cancer blood vessels to vascular density and metastasis, assessed by expression of a novel basement membrane component, LH39

S. Fox, A. Harris, A. Giatromanolaki, 2000, British Journal of Cancer.

Autophagy and hypoxia in colonic adenomas related to aggressive features

K. Gatter, A. Giatromanolaki, M. Koukourakis, 2013, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Guidelines for the use and interpretation of assays for monitoring autophagy

Robert Clarke, Hong Jiang, Hiroyuki Ishida, 2012 .

Prognostic relevance of light chain 3 (LC3A) autophagy patterns in colorectal adenocarcinomas

A. Harris, K. Gatter, A. Giatromanolaki, 2010, Journal of Clinical Pathology.

Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer

K. O'Byrne, A. Giatromanolaki, H. Turley, 2000, British Journal of Cancer.

HIF1α-dependent and independent pathways regulate the expression of PD-L1 in prostate cancer

A. Giatromanolaki, M. Koukourakis, C. Kalaitzis, 2023, Medical Oncology.

Serum VEGF levels and tissue activation of VEGFR2/KDR receptors in patients with breast and gynecologic cancer.

I. Tentes, A. Giatromanolaki, E. Kontomanolis, 2011, Cytokine.

Phase I/II Trial of Bevacizumab and Radiotherapy for Locally Advanced Inoperable Colorectal Cancer: Vasculature-Independent Radiosensitizing Effect of Bevacizumab

A. Harris, A. Giatromanolaki, F. Buffa, 2009, Clinical Cancer Research.

Prognostic and Predictive Role of Lactate Dehydrogenase 5 Expression in Colorectal Cancer Patients Treated with PTK787/ZK 222584 (Vatalanib) Antiangiogenic Therapy

A. Harris, G. Folprecht, K. Gatter, 2011, Clinical Cancer Research.

Guidelines for the use and interpretation of assays for monitoring autophage

T. P. Neufeld, Thomas J. Begley, H. Coller, 2012 .

Proliferating fibroblasts at the invading tumour edge of colorectal adenocarcinomas are associated with endogenous markers of hypoxia, acidity, and oxidative stress

A. Giatromanolaki, M. Koukourakis, E. Sivridis, 2005, Journal of Clinical Pathology.

Overexpression of LC3A autophagy protein in follicular and diffuse large B-cell lymphomas.

A. Harris, K. Gatter, A. Giatromanolaki, 2013, Hematology/oncology and stem cell therapy.

Tumorigenesis and Neoplastic Progression LC3A-Positive Light Microscopy Detected Patterns of Autophagy and Prognosis in Operable Breast Carcinomas

A. Harris, D. Ferguson, K. Gatter, 2010 .

Tumor-infiltrating lymphocytes, PD-L1, and MMR-deficiency combined characterization may identify subgroups of rectal cancer patients who would benefit from immunotherapy

A. Giatromanolaki, M. Koukourakis, M. Kouroupi, 2023, Immunobiology.

Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer.

V. Georgoulias, K. Gatter, G. Powis, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phytobezoars as a cause of small bowel obstruction associated with a carcinoid tumor of the ileocecal area.

A. Tsaroucha, A. Giatromanolaki, M. Koukourakis, 2003, Acta chirurgica Iugoslavica.

Treatment of non-small-cell lung cancer with prolonged oral etoposide.

S. Agelaki, V. Georgoulias, G. Chalkiadakis, 1998, American journal of clinical oncology.

Platelet‐derived endothelial cell growth factor (Thymidine Phosphorylase) expression in lung cancer

A. Harris, K. O'Byrne, K. Gatter, 1997, The Journal of pathology.

Postoperative pelvic hypofractionated accelerated radiotherapy with cytoprotection (HypoARC) for high-risk or recurrent prostate cancer.

M. Koukourakis, S. Touloupidis, I. Abatzoglou, 2012, Anticancer research.

Upregulated hypoxia inducible factor-1α and -2α pathway in rheumatoid arthritis and osteoarthritis

K. Gatter, A. Giatromanolaki, M. Koukourakis, 2003, Arthritis research & therapy.